Clinical trial
Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease
NCT07451613 is registered in ClinicalTrials.gov with Leslie Thompson as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1B/2A Study of the Safety and Tolerability of Human Neural Stem Cells for Huntington's Disease
- Lead sponsor
- Leslie Thompson
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- April 6, 2026
- Completion date
- January 31, 2031
- Enrollment
- 21 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.